CIP
ATRC icon

Champlain Investment Partners’s AtriCure ATRC Stock Holding History

Champlain Investment Partners’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.7M Sell
971,111
-202,494
-17% -$6.91M 0.35% 96
2025
Q4 		$46.4M Sell
1,173,605
-804,608
-41% -$29.5M 0.47% 85
2025
Q3 		$69.7M Sell
1,978,213
-38,541
-2% -$1.33M 0.53% 81
2025
Q2 		$66.1M Sell
2,016,754
-121,209
-6% -$3.94M 0.46% 93
2025
Q1 		$69M Sell
2,137,963
-390,651
-15% -$14.5M 0.5% 85
2024
Q4 		$77.3M Sell
2,528,614
-262,144
-9% -$8.43M 0.49% 88
2024
Q3 		$78.3M Buy
2,790,758
+115,813
+4% +$2.85M 0.47% 86
2024
Q2 		$60.9M Sell
2,674,945
-6,055
-0.2% -$140K 0.37% 98
2024
Q1 		$81.6M Buy
2,681,000
+575,605
+27% +$19.3M 0.47% 87
2023
Q4 		$75.1M Buy
2,105,395
+253,855
+14% +$9.44M 0.45% 89
2023
Q3 		$81.1M Buy
1,851,540
+41,155
+2% +$2.01M 0.53% 82
2023
Q2 		$89.4M Sell
1,810,385
-81,710
-4% -$3.77M 0.55% 78
2023
Q1 		$78.4M Sell
1,892,095
-47,645
-2% -$1.98M 0.49% 86
2022
Q4 		$86.1M Sell
1,939,740
-71,000
-4% -$2.97M 0.55% 80
2022
Q3 		$78.6M Buy
2,010,740
+391,760
+24% +$17.9M 0.54% 82
2022
Q2 		$66.2M Buy
1,618,980
+343,160
+27% +$16.3M 0.43% 95
2022
Q1 		$83.8M Buy
1,275,820
+57,270
+5% +$3.71M 0.43% 91
2021
Q4 		$84.7M Sell
1,218,550
-1,970
-0.2% -$143K 0.38% 103
2021
Q3 		$84.9M Sell
1,220,520
-340,715
-22% -$26.2M 0.41% 99
2021
Q2 		$124M Sell
1,561,235
-613,905
-28% -$44.6M 0.59% 76
2021
Q1 		$143M Buy
2,175,140
+39,560
+2% +$2.44M 0.74% 59
2020
Q4 		$119M Buy
2,135,580
+66,160
+3% +$2.86M 0.68% 64
2020
Q3 		$82.6M Buy
2,069,420
+410,185
+25% +$17.4M 0.56% 69
2020
Q2 		$74.6M Sell
1,659,235
-33,990
-2% -$1.48M 0.54% 74
2020
Q1 		$56.9M Buy
1,693,225
+443,585
+35% +$15.9M 0.51% 77
2019
Q4 		$40.6M Buy
1,249,640
+574,205
+85% +$16.3M 0.3% 104
2019
Q3 		$16.8M Buy
+675,435
New +$19.3M 0.14% 112

Other funds holding ATRC

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Champlain Investment Partners's ATRC Position: Q1 2026 in Review

Champlain Investment Partners reduced its AtriCure (ATRC) stake by 17% in Q1 2026, selling an estimated $6.91M and leaving 971,111 shares worth $27.7M. The position accounts for 0.35% of the portfolio, ranked #96.

Champlain Investment Partners first reported a position in ATRC in Q3 2019 and has held it in 27 quarters since. The position peaked at $143M in Q1 2021. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Champlain Investment Partners held 971,111 shares of AtriCure worth $27.7M as of Q1 2026.
  • Champlain Investment Partners sold 202,494 AtriCure shares in Q1 2026, an estimated $6.91M.
  • AtriCure made up 0.35% of Champlain Investment Partners's portfolio in Q1 2026, its #96 holding.
  • Champlain Investment Partners first reported a position in AtriCure in Q3 2019 and has held it in 27 quarters since.
  • Champlain Investment Partners's AtriCure position peaked at $143M in Q1 2021.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Champlain Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.